Page last updated: 2024-08-18

pyrazolanthrone and Diabetic Cardiomyopathies

pyrazolanthrone has been researched along with Diabetic Cardiomyopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, L; Liang, G; Liu, Q; Liu, Y; Miao, X; Sun, J; Tan, Y; Wang, Y; Zheng, Y; Zhou, S1

Other Studies

1 other study(ies) available for pyrazolanthrone and Diabetic Cardiomyopathies

ArticleYear
Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ-induced diabetes.
    Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:6

    Topics: Animals; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Apoptosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Curcumin; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; JNK Mitogen-Activated Protein Kinases; Male; Mast Cells; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Phosphorylation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2014